- Report
- October 2025
- 278 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,161GBP
- Report
- December 2024
- 200 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,548GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,548GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2663EUR$3,000USD£2,322GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,548GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,161GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1110EUR$1,250USD£967GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1110EUR$1,250USD£967GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1110EUR$1,250USD£967GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1110EUR$1,250USD£967GBP
- Report
- January 2025
- 194 Pages
Global
From €7057EUR$7,950USD£6,153GBP
- Report
- September 2025
- 128 Pages
Global
From €4349EUR$4,900USD£3,792GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- January 2025
- 182 Pages
Global
From €3994EUR$4,500USD£3,483GBP
- Report
- September 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,980GBP
- Report
- March 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,980GBP
€4305EUR$4,850USD£3,754GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,158GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,158GBP

The Blood Brain Barrier (BBB) is a specialized membrane that separates the brain from the rest of the body. It is composed of tightly packed cells that form a barrier to protect the brain from potentially harmful substances. The BBB is an important factor in the development of Central Nervous System (CNS) drugs, as it can limit the effectiveness of certain drugs. To overcome this, drug developers must create drugs that can cross the BBB and reach the target area in the brain. This requires a deep understanding of the BBB and its components, as well as the development of new drug delivery systems.
The BBB market is an important part of the CNS drug market, as it provides the necessary tools to develop effective drugs. Companies in this market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more